References
- American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997;156:S1-25 https://doi.org/10.1164/ajrccm.156.2.atsstatement
- Yim JJ, Park YK, Lew WJ, Bai GH, Han SK, Shim YS. Mycobacterium kansasii pulmonary diseases in Korea. J Korean Med Sci 2005;20:957-60 https://doi.org/10.3346/jkms.2005.20.6.957
- Griffith DE. Management of disease due to Mycobacterium kansasii. Clin Chest Med 2002;23: 613-21 https://doi.org/10.1016/S0272-5231(02)00016-3
- Koh WJ, Kwon OJ, Suh GY, Chung MP, Kim HJ, Lee NY, et al. A case report of three patients with nontuberculous mycobacterial pulmonary disease caused byMycobacterium kansasii. Tuberc Respir Dis 2003; 54:459-66 https://doi.org/10.4046/trd.2003.54.4.459
- Scientific Committee in Korean Academy of Tuberculosis and Respiratory Diseases. National survey of mycobacterial diseases other than tuberculosis in Korea. Tuberc Respir Dis 1995;42:277-94 https://doi.org/10.4046/trd.1995.42.3.277
- Maliwan N, Zvetina JR. Clinical features and follow up of 302 patients with Mycobacterium kansasii pulmonary infection: a 50 year experience. Postgrad Med J 2005;81:530-3 https://doi.org/10.1136/pgmj.2004.026229
- Aberg JA, Yajko DM, Jacobson MA. Eradication of AIDS-related disseminated Mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy. J Infect Dis 1998;178:1446-9 https://doi.org/10.1086/314469
- Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL, et al. Infection withMycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989;321:863-8 https://doi.org/10.1056/NEJM198909283211304
- Park SY, Park JH, Jegal YJ, Lee JH, Lim CM, Lee SD, et al. Acase of idiopathic CD4+T-lymphocytopenia with disseminated Mycobacterium kansasii infection and pulmonary alvelolar proteinosis. Tuberc Respir Dis 2000;48:377-82 https://doi.org/10.4046/trd.2000.48.3.377
- Bloch KC, Zwerling L, Pletcher MJ, Hahn JA, Gerberding JL, Ostroff SM, et al. Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study. Ann Intern Med 1998;129:698-704 https://doi.org/10.7326/0003-4819-129-9-199811010-00004
- Corbett EL, Blumberg L, Churchyard GJ, Moloi N, Mallory K, Clayton T, et al. Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners. Am J Respir Crit Care Med 1999;160:15-21 https://doi.org/10.1164/ajrccm.160.1.9812080
- Ahn CH, Lowell JR, Ahn SS, Ahn S, Hurst GA. Chemotherapy for pulmonary disease due to Mycobacterium kansasii: efficacies of some individual drugs. Rev Infect Dis 1981;3:1028–34
- Witzig RS, Fazal BA, Mera RM, Mushatt DM, Dejace PM, Greer DL, et al. Clinical manifestations and implications of coinfection withMycobacterium kansasii and human immunodeficiency virus type 1. Clin Infect Dis 1995;21:77-85 https://doi.org/10.1093/clinids/21.1.77
- Manali ED, Tomford WJ, Liao DW, Farver C, Mehta AC. Mycobacterium kansasii endobronchial ulcer in a nonimmunocompromised patient. Respiration 2005; 72:305-8 https://doi.org/10.1159/000085373